Omid Farokhzad & Seer, Inc.

Omid Farokhzad: Omid Farokhzad, M.D., who is the Chair and CEO of Seer, submitted an unsolicited, non-binding proposal to acquire all outstanding shares of Seer's Class A common stock.

Seer, Inc.: Seer received an unsolicited acquisition proposal from its Chair and CEO, Omid Farokhzad, M.D., which could lead to its acquisition or other strategic alternatives. The company's Board of Directors will establish a Special Committee to evaluate the proposal.

Omid Farokhzad: Omid Farokhzad, Chair and CEO of Seer, Inc., commented on the significance of the patent decisions, emphasizing Seer, Inc.'s commitment to defending its intellectual property.

Seer, Inc.: Seer, Inc. is the primary complainant in the patent infringement cases, seeking to protect its intellectual property related to nanoparticle protein enrichment technology. The favorable decisions from the International — European Patent Office and the U.S. International Trade Commission strengthen its market position and intellectual property portfolio.